Cargando…

First in man study: Bcl-Xl_42-CAF(®)09b vaccines in patients with locally advanced prostate cancer

BACKGROUND: The B-cell lymphoma-extra-large (Bcl-XL) protein plays an important role in cancer cells’ resistance to apoptosis. Pre-clinical studies have shown that vaccination with Bcl-XL-derived peptides can induce tumor-specific T cell responses that may lead to the elimination of cancer cells. Fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mørk, Sofie Kirial, Kongsted, Per, Westergaard, Marie Christine Wulff, Albieri, Benedetta, Granhøj, Joachim Stoltenborg, Donia, Marco, Martinenaite, Evelina, Holmström, Morten Orebo, Madsen, Kasper, Kverneland, Anders H., Kjeldsen, Julie Westerlin, Holmstroem, Rikke Boedker, Lorentzen, Cathrine Lund, Nørgaard, Nis, Andreasen, Lars Vibe, Wood, Grith Krøyer, Christensen, Dennis, Klausen, Michael Schantz, Hadrup, Sine Reker, thor Straten, Per, Andersen, Mads Hald, Svane, Inge Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043415/ https://www.ncbi.nlm.nih.gov/pubmed/36999039 http://dx.doi.org/10.3389/fimmu.2023.1122977

Ejemplares similares

Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial
por: Lorentzen, Cathrine Lund, et al.
Publicado: (2022)

A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
por: Kjeldsen, Julie Westerlin, et al.
Publicado: (2021)

Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
por: Kjeldsen, Julie Westerlin, et al.
Publicado: (2022)

Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes
por: Hulen, Thomas Morgan, et al.
Publicado: (2023)

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
por: Kverneland, Anders Handrup, et al.
Publicado: (2021)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012)

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma
por: Mørk, Sofie Kirial, et al.
Publicado: (2022)

Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2021)

MHC-based detection of antigen-specific CD8(+) T cell responses
por: Hadrup, Sine Reker, et al.
Publicado: (2010)

Comment on “5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity”
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

Evolution of MHC-based technologies used for detection of antigen-responsive T cells
por: Bentzen, Amalie Kai, et al.
Publicado: (2017)

T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation
por: Bentzen, Amalie Kai, et al.
Publicado: (2019)

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
por: Iversen, Trine Zeeberg, et al.
Publicado: (2013)

“Immunotherapy of cancer: present status and future promise”: Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd–25th September 2013
por: Donia, Marco, et al.
Publicado: (2014)

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
por: Grauslund, Jacob Handlos, et al.
Publicado: (2023)

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab
por: Lorentzen, Cathrine Lund, et al.
Publicado: (2023)

The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase
por: Sørensen, Rikke Bæk, et al.
Publicado: (2009)

Broadening the repertoire of melanoma-associated T-cell epitopes
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
por: Ellebaek, Eva, et al.
Publicado: (2012)

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
por: Hadrup, Sine, et al.
Publicado: (2012)

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
por: Bjoern, Jon, et al.
Publicado: (2018)

Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
por: Bjoern, Jon, et al.
Publicado: (2017)

T Cell Epitope Prediction and Its Application to Immunotherapy
por: Schaap-Johansen, Anna-Lisa, et al.
Publicado: (2021)

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
por: Klausen, Uffe, et al.
Publicado: (2018)

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
por: Viborg, Nadia, et al.
Publicado: (2019)

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
por: Araujo B. de Lima, Vinicius, et al.
Publicado: (2021)

Herpesvirus immunology in solid organ transplant recipients – liver transplant study (HISTORY): a retrospective and prospective observational cohort study
por: Suarez-Zdunek, Moises Alberto, et al.
Publicado: (2023)

High frequency of T cells specific for cryptic epitopes in melanoma patients
por: Andersen, Rikke Sick, et al.
Publicado: (2013)

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
por: Handlos Grauslund, Jacob, et al.
Publicado: (2021)

A bacterial display system for effective selection of protein-biotin ligase BirA variants with novel peptide specificity
por: Granhøj, Jeff, et al.
Publicado: (2019)

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
por: Borch, Troels Holz, et al.
Publicado: (2014)

Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with metastatic melanoma
por: Donia, Marco, et al.
Publicado: (2015)

Immune Mechanisms in Myelodysplastic Syndrome
por: Glenthøj, Andreas, et al.
Publicado: (2016)

Optimization in Detection of Antigen‐Specific T Cells Through Differentially Labeled MHC Multimers
por: Pedersen, Natasja Wulff, et al.
Publicado: (2019)

Improved T cell receptor antigen pairing through data-driven filtering of sequencing information from single cells
por: Povlsen, Helle Rus, et al.
Publicado: (2023)

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
por: Carnaz Simões, Ana Micaela, et al.
Publicado: (2022)

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression
por: Simões, Ana Micaela Carnaz, et al.
Publicado: (2022)

Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens
por: Holmström, Morten Orebo, et al.
Publicado: (2020)

TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
por: Tvingsholm, Siri Amanda, et al.
Publicado: (2023)

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lk4oln3au32p85mq0tk7o3618m